Specialist practitioner delivering a comprehensive clinical pharmacy service to oncology, haematology and palliative care patients on the ward, day unit and outpatients at St Lukes Cancer Centre (SLCC) and the outreach chemotherapy sites in accordance with objectives set by the senior pharmacist. Support the provision of the Trust Wide Research strategy by supporting the Pharmacy Clinical Trials team and taking an active role in the set up and delivery of oncology clinical trials. Provision of clinical and professional input to the day-to-day operation of the pharmacy service to SLCC. Active member of the oncology pharmacy team. Support the provision of a Trust Wide Medicines Management service. Provide out of hours emergency pharmacy services if required. Member of the oncology pharmacy team, providing a specialist clinical pharmacy service to patients treated at SLCC. As a Cancer Centre, SLCC serves a population of 1.2 Million patients, of all tumour sites, from across the St Lukes Cancer Alliance. Provision of a specialist clinical pharmacy service at the outreach chemotherapy sites (Frimley Health NHS FT, Ashford and St Peters NHS FT). This will be on a sessional basis according to the needs of the service. Will include working as a lone practitioner with only remote supervision. Provide support to the Pharmacy Clinical Trials team in all aspects of the set up and delivery of oncology clinical trials as required. As part of the clinical pharmacy team, may be required to provide a clinical pharmacy service to oncology inpatients (including surgical oncology) taking responsibility for a minimum of 30 patients on an average ward. Supervise the work of technical staff, pre-registration pharmacists and band 6 pharmacists. Work with the Deputy Chief Pharmacist (Cancer, Aseptic and Research Services) to provide pharmaceutical input into the management of oncology drugs. Contribute to the implementation of protocol guidelines, specifying drug doses and clinical details required for the safe administration of chemotherapy drugs for all tumour sites treated at SLCC, i.e. breast, colorectal & and gastro-intestinal, lung, gynaecological tumours, urological tumours, brain, head & neck tumours and haematological malignancies. The post holder is guided by medicines legislation, Good Clinical Practice (GCP), departmental and hospital policies and the code of ethics of the Royal Pharmaceutical Society (RPS),